READ
Is network expansion the booster dose diagnostic firms need
Pharma Profits Set To Surge, Says InCred's Aditya Khemk
Five interesting stocks from TIA’s 20-20 Ideas Summit
Daily Voice | This fund manager sees valuation comfort as a good entry point in consumer durables
What are the biggest threats to Indian equity markets in 2023
ETMarkets Fund Manager Talk: Rupee depreciation “single most” key risk for Indian equities: Aditya Sood, InCred AMC
D-Street rides on hopes of Fed turning less hawkish; some prefer caution
Analysts bullish on hospitals on expansion plans, recovery in non-Covid biz
Why Not Mint Money
Has the pharma sector become attractive after the recent market correction
Time to invest in pharma funds for a contrarian play
Small-caps look set for a rebound but note the risks as well
Is positive sentiment building on small-cap stocks
Daily Voice | Focus on management commentary, FY24 outlook, suggests Aditya Sood of InCred PMS
ETMarkets Smart Talk: Rising rates could impact profitability of small & midcaps, says Aditya Sood of InCred PMS
Sun Pharma To Cipla, How Indian Drugmakers Are Defying Pricing Pressure In U.S.
Don't base your investment decisions on market levels if you want to build robust long-term portfolio
In conversation with Mrinal Singh, CEO and CIO, InCred Asset Management
These 11 smallcap stocks delivered up to 1,700% returns in 2022 do you own any?
Will power sector's spark continue in 2023? Here's what analysts say
Rs 5.50 lakh crore! Here are 5 biggest mutual funds’ bets. Key details
TCS, Wipro, Infosys among 20 Nifty stocks that eroded Rs 10 lakh cr investor wealth in 2022